«Not only that, but in testing two doses of rivaroxaban, we found that we have the option of lowering the daily dose for extended treatment,» said Dr. Jeffrey Weitz, principal investigator of the study and professor of medicine and biochemistry and biomedical sciences at the Michael G. DeGroote School of Medicine at McMaster University. (sciencedaily.com)
An international research team with prominent Canadian leadership has found that the blood thinner rivaroxaban is as safe as aspirin, and more effective at preventing recurrence of life - threatening blood clots in the legs and lungs, according to a study published in the New England Journal of Medicine. (sciencedaily.com)
There was no significant difference between dabigatran and rivaroxaban in length of stay. (ucsf.edu)